secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2026-01-15T23:59:59+00:00
Accession:  0001140361-26-001268
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys granted 180-day extension to cure Nasdaq minimum bid price deficiency
-----------------------------------------------------------------------------

- Received Nasdaq deficiency notice July 16, 2025; bid price below $1.00 for 30 consecutive days.
- Granted extension to July 13, 2026 after requesting 180-day extension on Jan 12, 2026.
- Company reported stockholders' equity over $5M as of Dec 31, 2025; plans reverse stock split if needed.
- Common stock ticker FEMY remains listed on Nasdaq Capital Market during extension period.
- Non-compliance continues; risk of delisting if not cured by July 13, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036126001268/0001140361-26-001268-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036126001268/ef20063173_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-26-001268

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer